Axon Enterprise, Inc $AXON Shares Acquired by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. lifted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 11.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 21,325 shares of the biotechnology company’s stock after purchasing an additional 2,148 shares during the quarter. Rakuten Investment Management Inc.’s holdings in Axon Enterprise were worth $8,948,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. State Street Corp raised its holdings in Axon Enterprise by 5,700.2% in the 2nd quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock valued at $119,724,905,000 after buying an additional 209,879,882 shares during the period. Envestnet Asset Management Inc. lifted its position in Axon Enterprise by 18,050.2% in the second quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock valued at $7,400,094,000 after buying an additional 13,127,348 shares during the last quarter. BlackRock Inc. boosted its stake in Axon Enterprise by 4.3% during the second quarter. BlackRock Inc. now owns 8,334,551 shares of the biotechnology company’s stock worth $4,672,432,000 after buying an additional 345,365 shares during the period. Robeco Institutional Asset Management B.V. boosted its stake in Axon Enterprise by 391,214.9% during the third quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company’s stock worth $2,952,943,000 after buying an additional 6,987,098 shares during the period. Finally, Assenagon Asset Management S.A. boosted its stake in Axon Enterprise by 5,022.8% during the third quarter. Assenagon Asset Management S.A. now owns 4,266,589 shares of the biotechnology company’s stock worth $1,802,719,000 after buying an additional 4,183,302 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Price Performance

AXON opened at $382.56 on Friday. The stock’s 50-day moving average price is $447.49 and its 200 day moving average price is $476.73. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $665.07. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The firm has a market cap of $31.08 billion, a price-to-earnings ratio of 158.74, a PEG ratio of 8.06 and a beta of 1.48.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Thursday, November 5th. The biotechnology company reported $1.72 EPS for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). The firm had revenue of $908.55 million for the quarter, compared to analysts’ expectations of $934.33 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The business’s revenue was up 27.8% compared to the same quarter last year. During the same quarter last year, the business earned $1.17 earnings per share. As a group, sell-side analysts expect that Axon Enterprise, Inc will post 2.10 earnings per share for the current year.

Insider Buying and Selling at Axon Enterprise

In other news, insider Isaiah Fields sold 1,017 shares of the firm’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $480.45, for a total value of $488,617.65. Following the completion of the transaction, the insider owned 56,264 shares of the company’s stock, valued at approximately $27,032,038.80. This trade represents a 1.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey Kunins sold 9,605 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the completion of the transaction, the insider directly owned 97,761 shares of the company’s stock, valued at approximately $61,266,818.70. The trade was a 8.95% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 37,397 shares of company stock worth $21,234,034 over the last ninety days. Company insiders own 4.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on AXON. UBS Group lifted their price target on shares of Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a research report on Thursday, August 6th. Morgan Stanley upped their price objective on shares of Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. The Goldman Sachs Group lowered their price objective on shares of Axon Enterprise from $715.00 to $675.00 and set a “buy” rating for the company in a research report on Monday, September 21st. TD Cowen dropped their target price on shares of Axon Enterprise from $825.00 to $800.00 and set a “buy” rating for the company in a report on Monday, October 26th. Finally, Zacks Research downgraded shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $688.38.

Key Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon reported record Q3 revenue of $909 million, up 28% year over year, and returned to net income. Adjusted EBITDA rose 33% to $236 million. Axon Q3 results
• Positive Sentiment: Growth in newer offerings was strong: Drone as First Responder software and services revenue grew 43%, Platform Solutions revenue climbed 106%, and AI annual recurring revenue exceeded $100 million. Axon Q3 results
• Positive Sentiment: Axon invested an additional $1.2 billion in Skydio, raising its stake to 37% and making it Skydio’s exclusive public-safety distributor in the U.S. and Canada. The deal could strengthen Axon’s drone-response offering, though it requires substantial capital. Axon Skydio investment
• Negative Sentiment: Q3 adjusted earnings of $1.72 per share and revenue of about $909 million both missed analyst estimates, despite solid year-over-year growth. Q3 earnings and revenue miss
• Negative Sentiment: Axon’s Q4 revenue outlook of $990 million–$1.0 billion was below the roughly $1.1 billion consensus, while its full-year 2026 revenue outlook of $3.6 billion also trailed expectations of about $3.7 billion. Revenue outlook and Skydio investment
• Negative Sentiment: Zacks Research downgraded Axon from “strong buy” to “hold.” A lawsuit over the company’s AI-powered license-plate-reader network also presents potential legal uncertainty. License plate reader lawsuit

About Axon Enterprise

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company’s portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.